Skip to content
AnalystLens

Omega Healthcare Investors 8-K Report, Financial Results (Oct 30, 2025)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed October 30, 2025
Period End
October 30, 2025
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Jan ’23Jan ’23
  4. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 8-K filed October 30, 2025. Cited figures are marked; the original filing is the authoritative source.

Omega Healthcare Investors, Inc. (NYSE: OHI) reported third quarter 2025 results on October 30, 2025 via a press release attached as Exhibit 99.1.

Net income for the quarter was $185 milliona, or $0.59 per diluted share, versus $115 million, or $0.42 per diluted share, in Q3 2024. Adjusted FFO was $243 million, or $0.79 per diluted share, on 308 million weighted-average diluted shares, compared with $203 million, or $0.74 per diluted share, a year earlier. FAD was $231 million, or $0.75 per diluted share.

Management raised its 2025 AFFO guidance to $3.08 to $3.10b per diluted share, up from $3.04 to $3.07, and the company cited roughly $756 million of year-to-date real property and loan investments plus a $222 million joint venture investment as supporting it. The quarter's activity centered on balance sheet management and investment. Omega closed a new $2.3 billion senior unsecured credit facility on September 30, 2025, consisting of a $2.0 billion four-year revolver and a $300.0 million three-year delayed draw term loan, which replaced the prior $1.45 billion facility.

It also repaid $600 millionc of 5.25% senior unsecured notes at par on October 15, 2025, and extended a $428.5 million term loan to August 8, 2026. As of September 30, 2025, total indebtedness was $5.0 billion at a weighted average interest rate of 4.6%, and cash and cash equivalents were $737.2 million. In October 2025, the company formed a joint venture with affiliates of Saber Healthcare Holdings in which Omega acquired a 49% interest for Omega OP Units with a fair value of $222.4 million, covering 64 facilities that generate $69.4 million in annual contractual rent.

A separate agreement to acquire a 9.9% equity interest in Saber's operating company for $92.6 milliond is expected to close January 1, 2026. Operator exposure remained a focus. Genesis Healthcare, which filed for Chapter 11 on July 9, 2025, made all required rent and interest payments in the third quarter and paid its full contractual rent and interest of $4.4 million in October 2025.

The company also declared a quarterly dividend of $0.67 per share payable November 17, 2025. Operator coverage data showed twelve-month EBITDARM coverage before management fees of 1.91x and after management fees of 1.55x for the period ended June 30, 2025, with occupancy of 82.6%. Management described the backdrop as favorable and said the pipeline is very active.

Key Highlights

  1. Q3 2025 net income of $185 million ($0.59 per diluted share), up from $115 million ($0.42 per diluted share) in Q3 2024.
  2. Q3 2025 Adjusted FFO of $243 million ($0.79 per diluted share), up from $203 million ($0.74 per diluted share) a year earlier.
  3. 2025 AFFO guidance raised to $3.08 to $3.10 per diluted share, from $3.04 to $3.07.
  4. New $2.3 billion senior unsecured credit facility closed September 30, 2025, replacing the prior $1.45 billion facility; $600 million of 5.25% notes repaid October 15, 2025.
  5. October 2025 PropCo joint venture with Saber affiliates: 49% interest for Omega OP Units valued at $222.4 million, covering 64 facilities with $69.4 million in annual contractual rent.
  6. Pending $92.6 million investment for a 9.9% equity interest in Saber's operating company, expected to close January 1, 2026, with an 8% annualized minimum cash yield.
  7. Quarterly dividend of $0.67 per share declared October 24, 2025, payable November 17, 2025.

Frequently Asked Questions

  1. How did Omega perform in the third quarter of 2025?

    Net income was $185 million, or $0.59 per diluted share, compared with $115 million, or $0.42 per diluted share, in Q3 2024. Adjusted FFO was $243 million, or $0.79 per diluted share, versus $203 million, or $0.74 per diluted share, a year earlier. FAD was $231 million, or $0.75 per diluted share, compared with $192 million, or $0.70 per diluted share.

  2. Why did Omega raise its 2025 guidance?

    Management attributed the increase to nearly $1 billion of accretive investments year-to-date, including $756 million of real property and loan investments through September 2025 and the $222 million joint venture investment. The new AFFO guidance is $3.08 to $3.10 per diluted share, up from $3.04 to $3.07.

  3. What changed in Omega's debt and liquidity position?

    Omega entered a $2.3 billion senior unsecured credit facility on September 30, 2025, which replaced its $1.45 billion facility. It repaid $600 million of 5.25% senior unsecured notes at par on October 15, 2025, and extended a $428.5 million term loan to August 8, 2026. At September 30, 2025, total indebtedness was $5.0 billion at a 4.6% weighted average interest rate, with $737.2 million of cash and cash equivalents.

  4. What is the Saber joint venture and how does it affect Omega?

    In October 2025, Omega formed a JV with affiliates of Saber to own and lease 64 facilities previously wholly owned by Saber affiliates. Omega holds 49% of the JV in exchange for about 5.5 million Omega OP Units with a fair value of $222.4 million. The facilities are under triple net leases generating $69.4 million in annual contractual rent, and the JV's $448.6 million of mortgage debt is non-recourse to Omega.

  5. What is the status of the Genesis Healthcare exposure?

    Genesis filed for Chapter 11 on July 9, 2025. Omega provided an $8.0 million debtor-in-possession financing, fully funded as of the end of the third quarter. Genesis made all required contractual rent and interest payments in Q3 2025 and paid its full contractual rent and interest of $4.4 million in October 2025.